welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Thetis Pharmaceuticals Awarded Key Patent on HEALER Technology
Thetis Pharmaceuticals LLC, a privately-held biopharmaceutical company focused on gastrointestinal and cardiometabolic diseases, announced today that the USPTO has granted patent US 9,242,008 providing composition of matter protection for two Thetis development candidates, TP-252 for familial adenomatous polyposis and TP-452 for dyslipidemia. The allowed claims include pharmaceutical compositions that are mineral amino-acid based derivatives of fatty acids. National filings outside of the United States are underway.
expertly curated content related to this topic
-
emmanouil saloustrosHereditary cancer clinic at University h...
-
Bonnies Diary Jan 08https://jtvcancersupport.com/embed/29153...
-
Searchable Interface for Patient Education Information – Familial Adenomatous Polyposis (FAP)Familial Adenomatous Polyposis (FAP) is ...
-
Cancer Insurance ChecklistThe Cancer Insurance Checklist is design...
-
Evaluation of 28 Years of Surgical Treatment of Children and Young Adults with Familial Adenomatous PolyposisBACKGROUND : In this retrospective study...
-
Serum Nutrients and Habitual Dietary Intake in Colectomized FAP Patients in NorwayBACKGROUND : Patients with familial aden...
-
Lisa B. Aiello, MSN, RNLisa Aiello is an Assistant Clinical Pro...